Third-party lab testing: 3 independent Janoshik assays on file, covering 3 substances, most recent test 2024-06-07.
Peptide supplier identified through Janoshik analytical testing records.
Gideon Pharma is listed as active. Discovered via Janoshik third-party lab testing.
| Substance | Measured purity | Test date |
|---|---|---|
| Testosteron Enanthat 250 Mg/ml | not reported | 2024-06-07 |
| Testosteron Propionat 100 Mg/ml | not reported | 2024-06-07 |
| Boldenone Undecylenat 250 Mg/ml | not reported | 2024-06-07 |
None of these 3 assays carry a purity number on the certificate. They confirm the substance was submitted and tested, which is not the same as a measured result and not the same as a failure.
| Status | Active |
|---|---|
| Independent assays on file | 3 |
| Certificates of analysis | Vendor states COAs are available |
| Vendor type | Research-use supplier |
Gideon Pharma is listed as active and we hold 3 independent Janoshik assays on file. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. We hold 3 third-party Janoshik assays for Gideon Pharma, covering 3 substances. The most recent is dated 2024-06-07.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: GL Biochem Peptides Review, Glacier Aminos Peptides Review, Glamgurcraft Innovations Foreign Trade Peptides Review.